---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-034923"
form_type: "8-K"
ticker: "BLFS"
cik: "0000834365"
company_name: "BIOLIFE SOLUTIONS INC"
filed_at: "2023-10-23T23:59:59+00:00"
generated_at: "2026-06-09T17:47:46.519998+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# BioLife Solutions names Roderick de Greef CEO; prelim Q3 rev $33.3M, FY23 guidance at low end

## Summary
- Michael Rice resigns as CEO and Chairman; Roderick de Greef appointed President, CEO, and Chairman effective Oct 19, 2023.
- Preliminary Q3 2023 revenue $33.3M: cell processing $13.3M, storage $6.6M, freezers $13.4M.
- FY2023 revenue guidance narrowed to low end of $144M-$158M range; expects flat to modest Q4 cell processing growth.
- Garrie Richardson, former GM of biostorage and founder of SciSafe, promoted to Chief Revenue Officer.

## SEC filing metadata
- accession: 0001628280-23-034923
- form_type: 8-K
- ticker: BLFS
- cik: 0000834365
- company_name: BIOLIFE SOLUTIONS INC
- filed_at: 2023-10-23T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/834365/000162828023034923/0001628280-23-034923-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/834365/000162828023034923/blfs-20231019.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-034923
- JSON: https://secwatch.observer/filing/0001628280-23-034923.json
- Plain text: https://secwatch.observer/filing/0001628280-23-034923.txt

## Key facts
- Earnings Releases
  BIOLIFE SOLUTIONS INC reported the quarter ended September 30, 2023 results: revenue $33.3 million. Guidance reaffirmed.
  - Period: the quarter ended September 30, 2023
  - Revenue: $33.3 million
  - Guidance: reaffirmed
  - Result: preliminary results
  source text: Q3 Preliminary Unaudited Revenue and Updated FY2023 Guidance The Company is reporting preliminary, unaudited revenue for the third quarter of 2023 of approximately $33.3 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/834365/000162828023034923/0001628280-23-034923-index.htm
- Executive change
  Michael Rice resigned as Chief Executive Officer and Chairman at BIOLIFE SOLUTIONS INC.
  - Action: resigned
  - Role: Chief Executive Officer and Chairman
  source text: On October 19, 2023, Michael Rice, the Chief Executive Officer and Chairman of the Board of Directors (the “Board”) of the Company, resigned his positions as Chairman of the Board and Chief Executive Officer of the Company, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/834365/000162828023034923/0001628280-23-034923-index.htm
- Executive change
  Roderick de Greef was appointed as President and Chief Executive Officer and Chairman at BIOLIFE SOLUTIONS INC.
  - Action: appointed
  - Role: President and Chief Executive Officer and Chairman
  source text: On October 19, 2023, the Board appointed Roderick de Greef as the President and Chief Executive Officer of the Company (Principal Executive Officer) and Chairman of the Board, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/834365/000162828023034923/0001628280-23-034923-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.